B(0,+)-type amino acid transporter 1

From WikiMD's WELLNESSPEDIA

(Redirected from SLC7A9)

B(0,+)-type amino acid transporter 1 (B0AT1), also known as SLC6A19, is a protein that in humans is encoded by the SLC6A19 gene. It is a member of the solute carrier family 6, which includes neurotransmitter transporters, ion transporters, and amino acid transporters. B0AT1 is primarily expressed in the kidney and intestine, where it plays a crucial role in the absorption of neutral amino acids.

Structure[edit]

The B0AT1 protein is a multi-pass membrane protein, meaning it crosses the cell membrane multiple times. It is composed of 12 transmembrane domains with both the N- and C- termini located intracellularly. The protein also contains several potential glycosylation and phosphorylation sites, which may be involved in its regulation.

Function[edit]

B0AT1 functions as a sodium-dependent and chloride-independent transporter of neutral amino acids. This means it uses the sodium gradient across the cell membrane to drive the uptake of amino acids into the cell. The transporter has a broad substrate specificity, being able to transport a variety of neutral amino acids including leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, methionine, and others.

Clinical significance[edit]

Mutations in the SLC6A19 gene can lead to Hartnup disorder, a metabolic condition characterized by the impaired absorption of certain amino acids in the gut and kidney. Symptoms of Hartnup disorder can include skin rashes, neurological symptoms, and aminoaciduria.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.